Brian Wright
Stock Analyst at Roth MKM
(0.47)
# 4,178
Out of 5,093 analysts
31
Total ratings
27.59%
Success rate
-21.99%
Average return
Main Sectors:
Stocks Rated by Brian Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIOX Bioceres Crop Solutions | Maintains: Buy | $20 → $21 | $1.67 | +1,157.49% | 5 | Feb 9, 2024 | |
| ANDE The Andersons | Reiterates: Buy | $65 | $49.35 | +31.71% | 3 | Feb 6, 2024 | |
| BG Bunge Global | Maintains: Buy | $161 → $138 | $91.45 | +50.90% | 2 | Feb 5, 2024 | |
| ADM Archer-Daniels-Midland Company | Downgrades: Neutral | $98 → $66 | $58.07 | +13.66% | 2 | Jan 22, 2024 | |
| FMC FMC Corporation | Initiates: Buy | $74 | $13.37 | +453.48% | 1 | Jan 4, 2024 | |
| CTVA Corteva | Maintains: Buy | $82 → $63 | $65.84 | -4.31% | 2 | Nov 22, 2023 | |
| LNN Lindsay | Upgrades: Buy | $128 → $150 | $118.84 | +26.22% | 3 | Oct 23, 2023 | |
| PAHC Phibro Animal Health | Reiterates: Buy | $21 | $38.28 | -45.14% | 3 | Sep 1, 2023 | |
| UGRO urban-gro | Reiterates: Buy | $11 | $0.24 | +4,555.10% | 2 | Sep 1, 2023 | |
| XXII 22nd Century Group | Reiterates: Buy | $248,400 | $1.09 | +22,788,890.83% | 2 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $60 | $1.09 | +5,404.59% | 3 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $39 | $2.66 | +1,366.17% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $297 | $413.82 | -28.23% | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $0.98 | +12,153.65% | 1 | Oct 8, 2021 |
Bioceres Crop Solutions
Feb 9, 2024
Maintains: Buy
Price Target: $20 → $21
Current: $1.67
Upside: +1,157.49%
The Andersons
Feb 6, 2024
Reiterates: Buy
Price Target: $65
Current: $49.35
Upside: +31.71%
Bunge Global
Feb 5, 2024
Maintains: Buy
Price Target: $161 → $138
Current: $91.45
Upside: +50.90%
Archer-Daniels-Midland Company
Jan 22, 2024
Downgrades: Neutral
Price Target: $98 → $66
Current: $58.07
Upside: +13.66%
FMC Corporation
Jan 4, 2024
Initiates: Buy
Price Target: $74
Current: $13.37
Upside: +453.48%
Corteva
Nov 22, 2023
Maintains: Buy
Price Target: $82 → $63
Current: $65.84
Upside: -4.31%
Lindsay
Oct 23, 2023
Upgrades: Buy
Price Target: $128 → $150
Current: $118.84
Upside: +26.22%
Phibro Animal Health
Sep 1, 2023
Reiterates: Buy
Price Target: $21
Current: $38.28
Upside: -45.14%
urban-gro
Sep 1, 2023
Reiterates: Buy
Price Target: $11
Current: $0.24
Upside: +4,555.10%
22nd Century Group
Aug 23, 2023
Reiterates: Buy
Price Target: $248,400
Current: $1.09
Upside: +22,788,890.83%
Jul 21, 2023
Maintains: Buy
Price Target: $10 → $60
Current: $1.09
Upside: +5,404.59%
Apr 3, 2023
Maintains: Buy
Price Target: $78 → $39
Current: $2.66
Upside: +1,366.17%
Jun 3, 2022
Initiates: Buy
Price Target: $297
Current: $413.82
Upside: -28.23%
Oct 8, 2021
Initiates: Buy
Price Target: $120
Current: $0.98
Upside: +12,153.65%